Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer

被引：0
|
作者：
Kraeber-Bodere, F. [1 ,2 ]
Goldenberg, D. M. [3 ]
Chatal, J. F. [4 ]
Barbet, J. [2 ,4 ]
机构：
[1] Univ Hosp, Dept Nucl Med, Nantes, France
[2] Univ Nantes, INSERM, Canc Res Ctr, Nantes, France
[3] Ctr Mol Med & Immunol, Garden State Canc Ctr, Belleville, NJ USA
[4] Univ Nantes, Arronax Cyclotron, Nantes, France
来源：
CURRENT ONCOLOGY | 2009年 / 16卷 / 05期
关键词：
Pretargeted radioimmunotherapy; medullary thyroid cancer; calcitonin; BISPECIFIC ANTIBODY; PROGNOSTIC-FACTORS; BIVALENT HAPTEN; IMATINIB MESYLATE; FOLLOW-UP; CARCINOMA; SURVIVAL; CHEMOEMBOLIZATION; OPTIMIZATION; CALCITONIN;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：296 / 301
页数：6
相关论文
共 50 条
  • [21] Cabozantinib for progressive metastatic medullary thyroid cancer: a review
    Colombo, Joshua R.
    Wein, Richard O.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 395 - 404
  • [22] Diagnosis and treatment of medullary thyroid cancer
    Modigliani, E
    Franc, B
    Niccoli-sire, P
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (04) : 631 - 649
  • [23] The role of procalcitonin in the follow-up of medullary thyroid cancer
    Censi, Simona
    Manso, Jacopo
    Benvenuti, Teresa
    Piva, Ilaria
    Iacobone, Maurizio
    Mondin, Alberto
    Torresan, Francesca
    Basso, Daniela
    Crivellari, Gino
    Zovato, Stefania
    Mian, Caterina
    EUROPEAN THYROID JOURNAL, 2023, 12 (01)
  • [24] Pretargeted Molecular Imaging and Radioimmunotherapy
    Goldenberg, David M.
    Chang, Chien-Hsing
    Rossi, Edmund A.
    McBride, William J.
    Sharkey, Robert M.
    THERANOSTICS, 2012, 2 (05): : 523 - 540
  • [25] First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis
    Kocsis, Judit
    Szekanecz, Eva
    Bassam, Ali
    Uhlyarik, Andrea
    Papai, Zsuzsanna
    Rubovszky, Gabor
    Mezosi, Emese
    Rucz, Karoly
    Garai, Ildiko
    Nagy, Endre
    Uray, Ivan
    Horvath, Zsolt
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2019, 127 (04) : 240 - 246
  • [26] Carcinoembryonic antigen should be concurrently checked with calcitonin to identify distant metastases in medullary thyroid cancer
    Zheng-Pywell, Rui
    Cherian, Anish Jacob
    Enman, Macie
    Chen, Herbert
    Abraham, Deepak
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2020, 7 (01)
  • [27] Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature
    Appetecchia, Marialuisa
    Barnabei, Agnese
    Pompeo, Vincenzo
    Sentinelli, Steno
    Baldelli, Roberto
    Corsello, Salvatore Maria
    Torino, Francesco
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [28] MEDULLARY THYROID CANCER THAT STAINS NEGATIVE FOR CA 19-9 HAS DECREASED METASTATIC POTENTIAL
    Milman, Sofiya
    Arnold, Jeffrey L.
    Price, Melissa
    Negassa, Abdissa
    Surks, Martin I.
    Fleischer, Norman
    Whitney, Kathleen D.
    ENDOCRINE PRACTICE, 2015, 21 (06) : 590 - 594
  • [29] How I treat medullary thyroid cancer
    Kiesewetter, B.
    Riss, P.
    Scheuba, C.
    Raderer, M.
    ESMO OPEN, 2021, 6 (03)
  • [30] Ultrasonography features of medullary thyroid cancer as predictors of its biological behavior
    Kim, Cherry
    Baek, Jung Hwan
    Ha, Eunju
    Lee, Jeong Hyun
    Choi, Young Jun
    Song, Dong Eun
    Kim, Jae Kyun
    Chung, Ki-Wook
    Kim, Won Bae
    Shong, Young Kee
    ACTA RADIOLOGICA, 2017, 58 (04) : 414 - 422
12345